Pimitespib (trade name Jeselhy) is a drug for the treatment of gastrointestinal stromal tumors. It was discovered and developed by Taiho Pharmaceutical Co. The mechanism of action of pimitespib involves inhibition of heat shock protein 90 (Hsp90). In June 2022, it received approval in Japan for gastrointestinal stromal tumors that have progressed after chemotherapy.<\/p>\n
If pimitespib tablets are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
Jeselhy Tablets 40 mg (Pimitespib)<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":" Jeselhy (pimitespib) inhibits HSP90, thereby showing an antitumor effect by destabilizing and reducing proteins such as KIT, PDGFRA, HER2, and EGFR which are involved in the growth and survival of cancer. It is indicated for the treatment of gastrointestinal stromal tumors (GIST) that have progressed after chemotherapy. Jeselhy has been approved by the PMDA in Japan in June 2022.<\/p>\n DISEASE INDICATIONS-Gastric Cancer If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a>\u00a0in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201csotorasib tablets\u201d based on the information you provide.<\/p>\npimitespib tablets<\/h2>\n
Facts about pimitespib-tablets<\/h4>\n
\nMANUFACTURER-Taiho Pharmaceuticals
\nUSAGE-Oral
\nMEDICINE APPROVED BY-Pharmaceuticals and Medical Devices Agency (PMDA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n